James Kuo
Founder bei EXOPHARM
Vermögen: 146 760 $ am 31.03.2024
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Eric Weisblum | M | 54 | 14 Jahre | |
Joshua Schafer | M | 53 | 4 Jahre | |
Christopher Schaber | M | 57 | 18 Jahre | |
James Gilligan | M | 72 | 4 Jahre | |
Peter Molloy | M | 52 | 4 Jahre | |
Jennifer Bath | M | - | 6 Jahre | |
Gage Jull | M | 64 | 4 Jahre | |
Hugo Brugière | M | - | 2 Jahre | |
Jeff Pavell | M | 57 | 2 Jahre | |
Kevin Muñoz | M | 46 | 4 Jahre | |
Wayne Linsley | M | 67 | 4 Jahre | |
Gregg Lapointe | M | 65 | 15 Jahre | |
Xavier Paoli | M | - | 10 Jahre | |
Thomas W. Gosney | M | - |
OncoTracker, Inc.
OncoTracker, Inc. Pharmaceuticals: MajorHealth Technology OncoTracker, Inc. is a medical diagnostics company focusing on immuno-oncology. The firm involves research and drug discovery in hematological cancers. It provides therapies, sBCMA testing, and testing and services. The company was founded by James R Berenson in 2014 and is headquartered in West Hollywood, CA. | 5 Jahre |
Lawrence Steinman | M | 76 | 4 Jahre | |
Robert Rubin | M | 78 | 15 Jahre | |
Sidney Taubenfeld | M | - | 2 Jahre | |
Serguei Nabirotchkine | M | - | 17 Jahre | |
Joseph de Angelo | M | - |
ApoLife, Inc.
ApoLife, Inc. Miscellaneous Commercial ServicesCommercial Services ApoLife, Inc. provides screening and lab services. James S. Kuo has been the CEO of the American company since 2012. | - |
Raj Thota | M | - | 3 Jahre | |
Josh Lawler | M | - |
Return Health, Inc.
Return Health, Inc. BiotechnologyHealth Technology Return Health, Inc. develops and manufactures psychedelic medicines for dementia. The CEO of the American company is James S. Kuo. | - |
James O’Neill | M | 64 | 2 Jahre | |
Abhijit Pangu | M | - | 3 Jahre | |
Dirk Witters | M | - | 1 Jahre | |
Geraldine Kuo | F | - |
Athena Bioventures, Inc
Athena Bioventures, Inc Financial ConglomeratesFinance Athena Bioventures, Inc provides investment services. The private company is based in La Jolla, CA. The CEO of the company is Geraldine Kuo. | - |
Peter Guzzo | M | - | 4 Jahre | |
Antoine Gravelle | M | - | 2 Jahre | |
Melissa Israel | F | - | 4 Jahre | |
Barry Springer | M | - | 1 Jahre | |
Kristin Taylor | F | - | 1 Jahre | |
Anthony Ruizcalderon | M | - |
Return Health, Inc.
Return Health, Inc. BiotechnologyHealth Technology Return Health, Inc. develops and manufactures psychedelic medicines for dementia. The CEO of the American company is James S. Kuo. | - |
Payal Sahni Becher | F | - | 27 Jahre | |
Ilse Roodink | M | - | 3 Jahre | |
Joy K. Saha | M | - |
Athena Bioventures, Inc
Athena Bioventures, Inc Financial ConglomeratesFinance Athena Bioventures, Inc provides investment services. The private company is based in La Jolla, CA. The CEO of the company is Geraldine Kuo. | - |
Andrew Saich | M | - |
Return Health, Inc.
Return Health, Inc. BiotechnologyHealth Technology Return Health, Inc. develops and manufactures psychedelic medicines for dementia. The CEO of the American company is James S. Kuo. | - |
Henri Sant-Cassia | M | 47 |
Return Health, Inc.
Return Health, Inc. BiotechnologyHealth Technology Return Health, Inc. develops and manufactures psychedelic medicines for dementia. The CEO of the American company is James S. Kuo. | - |
Chris Buyse | M | 59 | 1 Jahre | |
Philippe Rinaudo | M | - | 9 Jahre | |
Guy-Charles Fanneau de la Horie | M | 64 | 1 Jahre | |
Susanne Dorn | F | - | 6 Jahre | |
Michael Silverman | M | - | - | |
Richard Gareth Skaife | M | - |
Return Health, Inc.
Return Health, Inc. BiotechnologyHealth Technology Return Health, Inc. develops and manufactures psychedelic medicines for dementia. The CEO of the American company is James S. Kuo. | - |
Adam T. Rumage | M | - | 17 Jahre | |
Gilbert Wagener | M | - | 1 Jahre | |
Daniel Ryweck | M | 59 | 2 Jahre | |
Christopher Ntoumenopoulos | M | - | 2 Jahre | |
Jason Carroll | M | - | 1 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Jeffrey Riley | M | 61 | 7 Jahre | |
Thomas D'Orazio | M | - | 1 Jahre | |
Robert Beecroft | M | - | 31 Jahre | |
Christopher P. Schnittker | M | 55 | - | |
Liisa Irmeli Laitinen | F | 69 | 18 Jahre | |
Garner William | M | 58 | 3 Jahre | |
Shepard M. Goldberg | M | 69 |
Cordex Pharma, Inc.
Cordex Pharma, Inc. Medical SpecialtiesHealth Technology Cordex Pharma, Inc. is a specialty pharmaceutical company that develops new cardiovascular medicines based upon the emerging pharmacology of adenosine 5'-triphosphate (ATP) and nitric oxide (NO). These two molecules play critical roles in cellular metabolism and signal transduction, the manipulation of which constitute novel therapeutic modalities for the treatment of major cardiovascular disorders. Cordex Pharma was founded on February 9, 1996 and is headquartered in Philadelphia, PA. | - |
Gregory M. McKee | M | 60 | 1 Jahre | |
Dave Tousley | M | 69 | 1 Jahre | |
Martin MacKay | M | 68 | 14 Jahre | |
Nelson K. Stacks | M | 53 | - | |
A. Joseph Rudick | M | 67 | 3 Jahre | |
David Solomon | M | 63 | 2 Jahre | |
Julie A. Caudill | F | - | - | |
George J. Brewer | M | - | - | |
Joseph M. Danis | M | - | 10 Jahre | |
Gianpaolo Andreola | M | 60 | 3 Jahre | |
Lisa Helbling | F | - | 4 Jahre | |
Robert Burke | M | - | 6 Jahre | |
Josie Taylor | F | - | - | |
Kris M. Maly | F | - | - | |
Piers John Morgan | M | 57 | 1 Jahre | |
Scott Tarriff | M | 64 | 8 Jahre | |
Alan Tuchman | M | 77 |
Cordex Pharma, Inc.
Cordex Pharma, Inc. Medical SpecialtiesHealth Technology Cordex Pharma, Inc. is a specialty pharmaceutical company that develops new cardiovascular medicines based upon the emerging pharmacology of adenosine 5'-triphosphate (ATP) and nitric oxide (NO). These two molecules play critical roles in cellular metabolism and signal transduction, the manipulation of which constitute novel therapeutic modalities for the treatment of major cardiovascular disorders. Cordex Pharma was founded on February 9, 1996 and is headquartered in Philadelphia, PA. | - |
Lyman Max Lyon | M | - | 1 Jahre | |
Michael Brown | M | 82 | 16 Jahre | |
Gregory Smith | M | 57 | 7 Jahre | |
Brad McConn | M | - | 1 Jahre | |
Charles Bisgaier | M | 71 | 2 Jahre | |
Michel de Rosen | M | 73 | 8 Jahre | |
Christopher S. Hassan | M | 63 | 4 Jahre | |
Christopher Scully | M | 53 | 20 Jahre | |
Dilip J. Mehta | M | 91 | 15 Jahre | |
Joshua Makower | M | 60 | - | |
Shauna M. Tholen | F | - | 3 Jahre | |
Martin Mattingly | M | 66 | 7 Jahre | |
Roxanne Lagano | F | 59 | - | |
Shankar Musunuri | M | 60 | 14 Jahre | |
Mary Winston | F | 62 | 7 Jahre | |
Randall Kaja | M | - | 15 Jahre | |
David L. Brinkley | M | 66 | - | |
David Simmons | M | 59 | 16 Jahre | |
Michael Berelowitz | M | 79 | 15 Jahre | |
Hugh M. Donnelly | M | - | - | |
David F. Fitzgerald | M | 90 | 26 Jahre | |
Liam Ratcliffe | M | 60 | 12 Jahre | |
Albert Lee Rauch | M | - | 6 Jahre | |
Ruth Simmons | M | 78 | 10 Jahre | |
Sep Sarshar | M | 57 | 3 Jahre | |
Jonathan Treherne | M | 62 | - | |
Peter S. Ringrose | M | 78 | 14 Jahre | |
Gerard G. Gorman | M | 73 | 5 Jahre | |
Pedro Lichtinger | M | 70 | 14 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 58 | 58,00% |
Kanada | 25 | 25,00% |
Frankreich | 16 | 16,00% |
Finnland | 1 | 1,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen